Northrop Grumman Corp (NOC US)
NOC US$552.77
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 552.77
- Change
- ▲ 1.54 (0.28)
- Bid / Ask
- 0.00 - 0.00
- Volume
- 217,515
- Turnover
- 105,772,895
- Open
- 547.69
- Day Range
- 547.69 - 554.97
- VWAP
- 552.48
- Prev Close
- 551.23
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Industrials
- Shares Issued
- 142,033,476
- NTA/Share
- -5.37
- Last Dividend
- 2.47
- Dividend Ex Date
- 31 AUG 2026
- Dividend Pay Date
- 16 SEP 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 41,954.00
- EBITDA
- 7,205.00
- Profit
- 4,182.00
- Earnings Per Share (EPS)
- 29.08
- Dividend Per Share (DPS)
- 8.99
- Yield %
- 1.77
- Market Cap
- 78,528.99
- Price to Earnings Ratio (P/E)
- 17.45
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 46,315.15
- EBITDA
- 6,564.00
- Profit
- 4,257.53
- Earnings Per Share (EPS)
- 30.12
- Dividend Per Share (DPS)
- 10.69
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Wide
- Financial Health
- Moderate
- Uncertainty
- Low
Morningstar Quantitative Rating as of 21 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 557.37 Fair value 603.84 One-star price 654.18
Morningstar Quantitative Rating as of 21 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 603.84
- Price / Fair Value
- 0.89
- Valuation
- Undervalued
- Uncertainty
- Low
Morningstar Quantitative Rating as of 21 OCT 2026. The slider runs from the five-star price (557.37) to the one-star price (654.18).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 539.31 |
| Price - 12 month high | 773.69 |
| Price - 12 month low | 470.50 |
| Pricing date | 20 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.07 |
| Market capitalization | 76,616.01 |
| 12 Month High price date | 3 MAR 2026 |
| 12 Month Low price date | 2 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 0.88 |
| Price - 1 Day % Change | 0.99% |
| Price - 13 week price percent change | 5.27% |
| Price - 26 week price percent change | -11.75% |
| Price - 5 Day % Change | 8.80% |
| Price - 52 week price percent change | -10.02% |
| Price - YTD price percent change | -6.14% |
| Price % Change Month To Date | 2.40% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 29.080 |
| EPS excluding extraordinary items - trailing 12 month | 31.680 |
| EPS Normalized - most recent fiscal year | 28.437 |
| Revenue/share - most recent fiscal year | 291.752 |
| Revenue/share - trailing 12 month | 305.848 |
| Book value per share - most recent fiscal year | 117.425 |
| Book value per share - most recent quarter | 131.512 |
| Book value (tangible) per share - most recent fiscal year | -5.373 |
| Book value (tangible) per share - most recent quarter | 8.750 |
| Cash per share - most recent fiscal year | 31.008 |
| Cash per share - most recent quarter | 26.355 |
| Cash Flow per share - most recent fiscal year | 39.082 |
| Cash Flow per share - trailing 12 month | 42.056 |
| Dividend per share - most recent fiscal year | 8.990 |
| Dividends per share - trailing 12 month | 9.560 |
| EBITD per share - trailing 12 month | 52.033 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 29.140 |
| EPS Basic excluding extraordinary items - trailing 12 month | 31.750 |
| EPS including extraordinary items - most recent fiscal year | 29.140 |
| EPS including extraordinary items - trailing 12 month | 31.750 |
| Free Cash Flow per share - trailing 12 month | 31.973 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 17.02 |
| P/E Normalized, most recent fiscal year | 16.61 |
| Price to sales - most recent fiscal year | 1.76 |
| Price to Tangible Book - most fiscal year | 61.64 |
| Price to Free Cash Flow per Share - most recent fiscal year | 16.87 |
| Price to Cash Flow per share - trailing 12 month | 12.82 |
| Price to Book - most recent fiscal year | 4.10 |
| P/E excluding extraordinary items high, trailing 12 months | 26.41 |
| P/E excluding extraordinary items low, trailing 12 months | 15.05 |
| Net Debt, LFI | 12,891.00 |
| Net Debt, LFY | 12,616.00 |
| Dividend Yield - 5 Year Average | 1.54% |
| Dividend Yield - indicated annual dividend divided by closing price | 1.79% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 1.77% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 4,170.00 |
| LT debt/equity - most recent fiscal year | 102.07% |
| Payout ratio - most recent fiscal year | 30.91% |
| Total debt/total equity - most recent fiscal year | 102.07% |
| LT debt/equity - most recent quarter | 89.04% |
| Total debt/total equity - most recent quarter | 89.04% |
| Free Cash Flow - trailing 12 month | 4,557.00 |
| Payout ratio - trailing 12 month | 28.38% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 41,954.00 |
| Revenue - trailing 12 month | 43,591.00 |
| EBITD - most recent fiscal year | 7,205.00 |
| EBITD - trailing 12 month | 7,416.00 |
| Earnings before taxes - most recent fiscal year | 5,068.00 |
| Earnings before taxes - trailing 12 month | 5,236.00 |
| Net Income available to common - most recent fiscal year | 4,182.00 |
| Net Income available to common - trailing 12 months | 4,520.00 |
| Earnings before taxes Normalized - most recent fiscal year | 4,956.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 32.46 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 9.97% |
| Net Profit Margin % - trailing 12 month | 10.37% |
| Operating margin - 1st historical fiscal year | 10.20% |
| Operating margin - trailing 12 month | 10.61% |
| Pretax margin - trailing 12 month | 12.01% |
| Pretax margin - 1st historical fiscal year | 12.08% |
| Operating Margin - 5 year average | 9.49% |
| Pretax Margin - 5 year average | 14.26% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 7.07% |
| Free Operating Cash Flow/Revenue, TTM | 10.45% |
| Net Profit Margin - 5 year average | 11.68% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 8.43% |
| Return on average assets - trailing 12 month | 8.90% |
| Return on average equity - most recent fiscal year | 26.67% |
| Return on average equity - trailing 12 month | 26.17% |
| Return on average assets - 5 year average | 9.40% |
| Return on average equity - 5 year average | 30.17% |
| Net Income/employee - most recent fiscal year | 44,021.05 |
| Revenue/employee - most recent fiscal year | 441,621.05 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 2.66% |
| EPS growth rate, 5 year | 8.85% |
| Growth rate% - dividend, 3 year | 9.97% |
| Revenue/share (5 yr growth) | 5.85% |
| Growth rate% - Revenue, 3 year | 4.65% |
| Growth rate% - EPS, 3 year | -2.60% |
| Book value per share growth rate, 5 year | 13.10% |
| Capital Spending growth rate, 5 year | 0.42% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 5.21% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systemscreates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
